Proof of concept reveals dual-targeting by Ru(II)/Ir(III) complexes affecting ferroptosis and apoptosis in TNBC.
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer which lacks effective targeted therapies because of negative expression of the targetable bioreceptors. Fighting with TNBC requires innovative...
No takes yet. Share an insight, caveat, or question.
Das et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: